Pharmaceutical Technology1h
AdvanCell raises $112m as radiopharma buzz continues
AdvanCell, an Australia-based radiopharmaceutical company, has raised $112m as investor interest in the radiopharma sector ...
Pharmaceutical Technology2h
MHRA seeks input on new regulatory guidance for cancer vaccines
The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
Pharmaceutical Technology5h
Pfizer’s colon cancer combo approval further supported by Phase III win
The colon cancer BRAFF mutation study is one of the first to be initiated under the FDA’s Project FrontRunner.
Pharmaceutical Technology9h
Celltrion’s Avtozma receives FDA approval for multiple conditions
The FDA has granted approval for Celltrion's Avtozma in both IV and SC formulations as Actemra biosimilar for treating ...
Pharmaceutical Technology11h
Sanofi’s Sarclisa combo approved in China for multiple myeloma
Sanofi has received China’s NMPA approval for the use of Sarclisa, combined with a standard-of-care regimen, for treating ...
Pharmaceutical Technology14h
ViiV Healthcare and J&J’s adolescent HIV-1 combo gains EC authorisation
The EC has authorised the use of ViiV Healthcare’s Vocabria plus Rekambys from J&J for treating adolescents with HIV-1.